T. Thompson

Dose-dense anthracycline-based chemotherapy for node-positive breast cancer.

R. Livingston, J. Gralow, S. Green, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).

B. Storer, D. Coldwell, N. Patel, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Multimodality treatment of non‐small cell lung cancer: Response to cisplatin, VP‐16, and 5‐FU chemotherapy and to surgery and radiation therapy

R. Thurer, K. Sridhar, E. Davila, 1988, Journal of surgical oncology.

Prolonged, alternating chemotherapy for extensive small cell lung cancer. A southwest oncology group study

J. Crowley, R. Livingston, F. Meyers, 1993 .

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report.

E. B. Butler, T. Wheeler, B. Miles, 2001, International journal of radiation oncology, biology, physics.

Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703).

L. Traverso, P. Weiden, C. Thomas, 1997, American journal of clinical oncology.